&nbsp;

metisTabsThumbTab.png

Sep 2019

Document

uiTabsThumbTab.png

Sep 2019

Document

uiTabsThumbTab-2.png

Oct 2019

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI)

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2024

Document

Understanding Your Assessment - PERSPECTIVE Study

Jan 2020

Regimen

MTRX(HD)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Drugs Used:

methotrexate,

leucovorin

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2020

Guidelines and Advice

Minimal Residual Disease Testing in Acute Leukemia

Status: Current
ID: MOTAC-6
Version: 2

Sep 2020

Document

MucinousOvarianCancerTreatmentPathwayMap_2020-01.pdf

Mar 2020

Regimen

MPC+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Funding:

ODB - General Benefit

procarbazine

Drugs Used:

riTUXimab (Unfunded),

Quick Link(s):

Regimen Monograph

Dec 2020

Cancer facts

Un niveau de revenu faible du ménage peut être un obstacle au renoncement au tabac à long terme

Jan 2021

Regimen

MFOLFOX6+TRAS

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Advanced Gastric, Gastroesophageal, or Esophageal Cancer

Drugs Used: